const mockArticles = [
{
id: 1,
title: "BYD's New Blade Battery Technology Achieves 1000km Range",
summary: "BYD announces breakthrough in battery density with their latest Blade Battery 2.0, promising 1000km range for EVs while maintaining safety standards.",
category: "EVs",
source: "TechNode",
author: "Li Wei",
publishedAt: "2025-09-07T10:00:00Z",
votes: 127,
comments: 23,
views: "2.1k",
readTime: "4 min read",
image: "https://images.unsplash.com/photo-1593941707882-a5bac6861d75?w=400&h=250&fit=crop",
featured: true,
tags: ["BYD", "Battery Technology", "Electric Vehicles", "Innovation"],
originalUrl: "https://technode.com/byd-blade-battery-2-breakthrough",
keyPoints: [
  "Revolutionary battery technology promises 1000km range for electric vehicles",
  "New Blade Battery 2.0 maintains industry-leading safety standards"
],
fullContent: {
  keyTakeaways: [
    "Revolutionary battery technology promises 1000km range for electric vehicles",
    "New Blade Battery 2.0 maintains industry-leading safety standards",
    "BYD's innovation could accelerate global EV adoption timeline",
    "Technology expected to reduce battery costs by 15-20% within two years"
  ],
  sections: [
    {
      heading: "The Breakthrough",
      content: `BYD has unveiled its next-generation Blade Battery 2.0, a lithium iron phosphate (LiFePO4) battery technology that promises to deliver up to 1000km of range in electric vehicles. This represents a significant leap forward from the company's original Blade Battery, which already set industry standards for safety and efficiency.

The new battery technology uses an innovative cell-to-pack design that eliminates traditional modules, increasing energy density by up to 50% while maintaining the structural integrity that made the original Blade Battery famous for its safety record.`
    },
    {
      heading: "What Makes It Different",
      content: `Unlike traditional battery packs that use cylindrical or pouch cells, BYD's Blade Battery uses long, thin cells that resemble knife blades—hence the name. The 2.0 version incorporates several key improvements:

**Enhanced Chemistry**: The new formulation improves energy density while maintaining thermal stability.
**Structural Integration**: The battery pack itself becomes part of the vehicle's structure, reducing weight and improving rigidity.
**Faster Charging**: Capable of 10-80% charging in under 30 minutes with compatible fast-charging infrastructure.`
    },
    {
      heading: "Market Impact",
      content: `Industry analysts expect BYD's Blade Battery 2.0 to accelerate EV adoption globally. The 1000km range addresses one of the primary concerns consumers have about electric vehicles—range anxiety.

"This is a game-changer for the industry," says Dr. Li Wei, automotive technology analyst at Shanghai Tech Research. "When you can drive from Beijing to Shanghai on a single charge, EVs become practical for virtually every use case."

The technology is expected to debut in BYD's premium Han EV sedan in Q2 2025, with plans to license the technology to other automakers beginning in 2026.`
    }
  ],
  bottomLine: "BYD's Blade Battery 2.0 could be the breakthrough that makes EVs truly mainstream. With 1000km range and proven safety, it addresses the two biggest barriers to EV adoption. The real test will be production scale and cost—but if BYD can deliver on both, this could accelerate the transition to electric vehicles by years, not decades."
}
},
{
id: 2,
title: "Baidu's Apollo AI Makes Major Autonomous Driving Breakthrough",
summary: "Baidu's latest AI model demonstrates Level 4 autonomous driving capabilities in complex urban environments across 10 Chinese cities.",
category: "AI",
source: "South China Morning Post",
author: "Zhang Ming",
publishedAt: "2025-09-07T08:30:00Z",
votes: 89,
comments: 15,
views: "1.8k",
readTime: "3 min read",
image: "https://images.unsplash.com/photo-1555949963-aa79dcee981c?w=400&h=250&fit=crop",
tags: ["Baidu", "Autonomous Driving", "AI", "Apollo"],
originalUrl: "https://scmp.com/baidu-apollo-breakthrough",
keyPoints: [
  "Baidu's Apollo achieves Level 4 autonomous driving in complex urban environments",
  "Successfully tested across 10 major Chinese cities"
],
fullContent: {
  keyTakeaways: [
    "Baidu's Apollo AI achieves Level 4 autonomous driving in urban environments",
    "Successfully tested across 10 major Chinese cities including Beijing and Shanghai",
    "New neural network architecture reduces processing time by 40%",
    "Commercial deployment planned for 2025 in select cities"
  ],
  sections: [
    {
      heading: "The Apollo Advantage",
      content: `Baidu's Apollo platform has achieved a significant milestone in autonomous driving technology, demonstrating Level 4 capabilities in complex urban scenarios across 10 Chinese cities. This breakthrough represents years of research and testing in some of the world's most challenging driving environments.

The latest iteration of Apollo uses advanced deep learning algorithms trained on over 100 million kilometers of real-world driving data, enabling it to handle complex scenarios like construction zones, emergency vehicles, and unpredictable pedestrian behavior.`
    },
    {
      heading: "Technical Innovation",
      content: `Apollo's success stems from several key innovations:

**Multi-Modal Sensor Fusion**: Combines LiDAR, cameras, and radar data in real-time for 360-degree environmental awareness.
**Predictive Path Planning**: AI predicts the behavior of other road users up to 8 seconds in advance.
**Edge Computing**: On-vehicle processing reduces latency to under 100 milliseconds for critical decisions.

The system has been tested in diverse conditions including heavy rain, snow, and complex traffic patterns unique to Chinese cities.`
    },
    {
      heading: "Commercialization Timeline",
      content: `Baidu plans to begin commercial deployment of Apollo-powered robotaxis in select Chinese cities by late 2025. The company has already secured partnerships with several automakers including FAW, BAIC, and Geely.

"We're moving from testing to real-world application," said Wang Yunpeng, General Manager of Baidu's Intelligent Driving Group. "Apollo represents the future of urban mobility in China and globally."

The technology will initially focus on fixed routes in controlled environments before expanding to full city-wide deployment.`
    }
  ],
  bottomLine: "Baidu's Apollo breakthrough puts China at the forefront of autonomous driving technology. While challenges remain around regulation and public acceptance, the technical capabilities demonstrated suggest that fully autonomous vehicles could become reality in Chinese cities sooner than many expected. This could reshape urban transportation and give China a significant advantage in the global autonomous vehicle market."
}
},
{
id: 3,
title: "China's Solar Panel Efficiency Reaches Record 26.8%",
summary: "LONGi Solar achieves new world record for silicon solar cell efficiency, surpassing previous benchmarks and reducing cost per watt.",
category: "Energy",
source: "PV Magazine",
author: "Chen Lu",
publishedAt: "2025-09-07T07:15:00Z",
votes: 156,
comments: 31,
views: "3.2k",
readTime: "5 min read",
image: "https://images.unsplash.com/photo-1508514177221-188b1cf16e9d?w=400&h=250&fit=crop",
tags: ["Solar", "LONGi", "Renewable Energy", "Efficiency"],
originalUrl: "https://pvmagazine.com/longi-solar-record",
keyPoints: [
  "LONGi Solar achieves new world record for silicon solar cell efficiency at 26.8%",
  "Breakthrough reduces cost per watt and improves solar panel economics"
],
fullContent: {
  keyTakeaways: [
    "LONGi Solar achieves world record 26.8% efficiency for silicon solar cells",
    "New technology reduces manufacturing costs by 12% compared to previous generation",
    "Breakthrough uses innovative PERC+ technology with advanced passivation",
    "Commercial production expected to begin in Q1 2026"
  ],
  sections: [
    {
      heading: "Record-Breaking Achievement",
      content: `LONGi Solar has achieved a new world record for silicon solar cell efficiency, reaching 26.8% conversion efficiency in laboratory conditions. This breakthrough surpasses the previous record of 26.7% and brings silicon technology closer to its theoretical maximum efficiency of around 29%.

The achievement was verified by the Institute for Solar Energy Research Hamelin (ISFH), an internationally recognized testing facility. This certification confirms LONGi's position as a leader in photovoltaic technology innovation.`
    },
    {
      heading: "Technology Behind the Breakthrough",
      content: `LONGi's record-breaking cell uses an advanced version of their PERC+ (Passivated Emitter Rear Cell) technology, which includes several key innovations:

**Advanced Passivation**: New materials reduce electron recombination, allowing more generated electricity to be captured.
**Optimized Light Trapping**: Microscopic texturing maximizes light absorption across the solar spectrum.
**Improved Metallization**: Better electrical contacts reduce power losses within the cell.

These improvements work together to extract maximum energy from sunlight while maintaining manufacturability at scale.`
    },
    {
      heading: "Market Implications",
      content: `The efficiency breakthrough has significant implications for solar adoption globally. Higher efficiency panels require less installation space and reduce balance-of-system costs, making solar more attractive for both residential and commercial applications.

"Every percentage point of efficiency improvement translates to real cost savings," explains Dr. Li Zhenguo, LONGi's founder and president. "This breakthrough brings us closer to grid parity in markets where solar isn't yet cost-competitive."

LONGi plans to begin commercial production of the high-efficiency cells in early 2026, with initial capacity of 5GW annually.`
    }
  ],
  bottomLine: "LONGi's efficiency record demonstrates China's continued leadership in solar technology. As efficiency approaches theoretical limits for silicon, the focus is shifting to manufacturing scale and cost reduction. This breakthrough suggests Chinese solar companies will maintain their competitive advantage in the global transition to renewable energy, potentially accelerating solar adoption worldwide."
}
},
{
id: 4,
title: "Alibaba Cloud Launches New AI Chip for Data Centers",
summary: "Alibaba's Yitian 710 chip promises 20% better performance than competitors while reducing energy consumption by 30%.",
category: "AI",
source: "TechCrunch",
author: "Wang Lei",
publishedAt: "2025-09-06T16:45:00Z",
votes: 203,
comments: 42,
views: "4.1k",
readTime: "4 min read",
image: "https://images.unsplash.com/photo-1518709268805-4e9042af2176?w=400&h=250&fit=crop",
tags: ["Alibaba", "AI Chips", "Data Centers", "Cloud Computing"],
originalUrl: "https://techcrunch.com/alibaba-yitian-710-chip",
keyPoints: [
  "Alibaba's Yitian 710 chip delivers 20% better performance than competitors",
  "New architecture reduces energy consumption by 30% in data center operations"
],
fullContent: {
  keyTakeaways: [
    "Alibaba's Yitian 710 chip delivers 20% better performance than competing processors",
    "Advanced ARM-based architecture reduces data center energy consumption by 30%",
    "Custom chip designed specifically for Alibaba Cloud's workloads and AI applications",
    "Deployment across Alibaba's global data center network begins in Q4 2025"
  ],
  sections: [
    {
      heading: "Custom Silicon Strategy",
      content: `Alibaba Cloud has unveiled its latest custom processor, the Yitian 710, marking a significant step in the company's strategy to reduce dependence on third-party chip suppliers. The processor is designed specifically for cloud computing workloads and represents years of investment in semiconductor capabilities.

Built on a 5nm manufacturing process, the Yitian 710 features 128 cores based on the ARM Neoverse architecture, optimized for the specific demands of Alibaba's cloud services and AI applications. This custom approach allows for better integration with Alibaba's software stack and more efficient resource utilization.`
    },
    {
      heading: "Performance Advantages",
      content: `Initial benchmarks show the Yitian 710 delivering impressive performance improvements:

**20% Better Performance**: Optimized instruction sets and cache hierarchy improve computational efficiency.
**30% Energy Reduction**: Advanced power management and specialized circuits reduce electricity consumption.
**Enhanced AI Workloads**: Dedicated accelerators for machine learning inference and training.

These improvements are particularly significant for Alibaba's e-commerce platform during peak shopping events like Singles' Day, where massive computational resources are required.`
    },
    {
      heading: "Strategic Implications",
      content: `The Yitian 710 represents China's growing capabilities in advanced semiconductor design, particularly for cloud computing applications. While Alibaba still relies on international foundries for manufacturing, the custom design gives the company more control over its technology stack.

"Custom silicon allows us to optimize for our specific use cases," said Jeff Zhang, President of Alibaba Cloud Intelligence. "This isn't just about performance—it's about creating a competitive advantage in cloud services."

The chip will power Alibaba's next-generation cloud instances, potentially offering customers better performance at lower costs.`
    }
  ],
  bottomLine: "Alibaba's Yitian 710 demonstrates how Chinese tech giants are investing in custom silicon to reduce dependencies and improve performance. While geopolitical tensions continue around semiconductor supply chains, innovations like this show Chinese companies developing sophisticated alternatives. The real test will be whether these custom chips can maintain their advantage as they scale to full production."
}
},
{
id: 5,
title: "Tencent's AI-Powered Drug Discovery Platform Shows Promise",
summary: "Tencent AI Lab's new drug discovery platform reduces molecule optimization time from months to days, targeting cancer and neurological diseases.",
category: "MedTech",
source: "Nature Biotechnology",
author: "Dr. Liu Xiaoming",
publishedAt: "2025-09-06T14:20:00Z",
votes: 178,
comments: 28,
views: "2.7k",
readTime: "6 min read",
image: "https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=400&h=250&fit=crop",
tags: ["Tencent", "Drug Discovery", "AI", "Biotechnology"],
originalUrl: "https://nature.com/tencent-ai-drug-discovery",
keyPoints: [
  "Tencent's AI platform reduces drug molecule optimization from months to days",
  "Technology targets cancer and neurological diseases with promising early results"
],
fullContent: {
  keyTakeaways: [
    "Tencent's AI platform accelerates drug molecule optimization by 100x",
    "Early trials show promise for cancer and Alzheimer's disease treatments",
    "Platform integrates quantum computing for complex molecular modeling",
    "Partnership with major pharmaceutical companies planned for 2026"
  ],
  sections: [
    {
      heading: "Revolutionary Approach",
      content: `Tencent AI Lab has developed a groundbreaking drug discovery platform that uses artificial intelligence to dramatically accelerate the identification and optimization of therapeutic compounds. The platform, called TenMol, can reduce molecule optimization cycles from months to just days.

Traditional drug discovery involves testing thousands of compounds in laboratory experiments, a process that can take years and cost hundreds of millions of dollars. TenMol uses machine learning algorithms trained on vast molecular databases to predict which compounds are most likely to be effective against specific diseases.`
    },
    {
      heading: "Technical Innovation",
      content: `TenMol combines several cutting-edge technologies:

**Deep Learning Models**: Neural networks trained on over 100 million molecular structures predict drug-target interactions.
**Quantum Computing**: Quantum algorithms model complex molecular behaviors that classical computers struggle with.
**Virtual Screening**: AI rapidly evaluates millions of potential compounds without physical synthesis.

The platform has already identified several promising candidates for cancer treatment, with early results showing 40% better binding affinity than conventional approaches.`
    },
    {
      heading: "Clinical Applications",
      content: `Tencent is focusing initial efforts on three key areas:

**Cancer Therapeutics**: Targeting specific protein interactions involved in tumor growth.
**Neurological Diseases**: Developing treatments for Alzheimer's and Parkinson's disease.
**Rare Diseases**: Addressing conditions with limited treatment options.

"AI allows us to explore molecular space in ways that weren't possible before," explains Dr. Zhang Tong, head of Tencent's biomedical AI team. "We can investigate millions of possibilities in the time it would take to test hundreds in the lab."

The first AI-discovered compounds are expected to enter clinical trials by 2027.`
    }
  ],
  bottomLine: "Tencent's entry into AI-powered drug discovery represents a significant shift in how pharmaceutical research may be conducted. While the technology is promising, the real test will be whether AI-discovered drugs prove safe and effective in human trials. If successful, this could democratize drug discovery and bring new treatments to market much faster than traditional methods."
}
},
{
id: 6,
title: "BGI Genomics Launches Portable DNA Sequencer for Rural Healthcare",
summary: "BGI's new portable sequencing device costs 90% less than traditional equipment, making genetic testing accessible in remote Chinese villages.",
category: "MedTech",
source: "Science Translational Medicine",
author: "Dr. Chen Wei",
publishedAt: "2025-09-06T12:30:00Z",
votes: 145,
comments: 19,
views: "1.9k",
readTime: "4 min read",
image: "https://images.unsplash.com/photo-1576091160399-112ba8d25d1f?w=400&h=250&fit=crop",
featured: false,
tags: ["BGI", "DNA Sequencing", "Rural Healthcare", "Genomics"],
originalUrl: "https://stm.sciencemag.org/bgi-portable-sequencer",
keyPoints: [
  "BGI's portable DNA sequencer costs 90% less than traditional equipment",
  "Device enables genetic testing in remote rural areas previously without access"
],
fullContent: {
  keyTakeaways: [
    "BGI's portable DNA sequencer reduces costs by 90% compared to traditional equipment",
    "Device weighs only 2kg and can operate on battery power for 8 hours",
    "Enables genetic testing for rare diseases in remote rural communities",
    "Plans to deploy 1,000 units across China's rural healthcare network by 2026"
  ],
  sections: [
    {
      heading: "Democratizing Genomics",
      content: `BGI Genomics has launched a revolutionary portable DNA sequencing device that could transform healthcare access in rural areas. The palm-sized sequencer, called BGI Mobile, costs just $3,000 compared to $30,000 for traditional laboratory equipment.

The device enables healthcare workers in remote villages to conduct genetic testing on-site, eliminating the need to transport samples to distant laboratories. This is particularly important for time-sensitive diagnoses and in areas where sample transportation is challenging.`
    },
    {
      heading: "Technical Specifications",
      content: `The BGI Mobile represents a significant engineering achievement:

**Miniaturization**: Advanced microfluidics pack laboratory capabilities into a 2kg device.
**Battery Operation**: 8-hour battery life enables use in areas without reliable electricity.
**Cloud Connectivity**: Results upload to BGI's cloud platform for expert analysis.
**Simplified Operation**: Touch-screen interface allows non-specialists to operate the device.

Despite its small size, the device maintains accuracy comparable to full-scale laboratory equipment for most common genetic tests.`
    },
    {
      heading: "Healthcare Impact",
      content: `The portable sequencer addresses a critical gap in China's healthcare system. While urban areas have access to advanced genetic testing, rural communities often lack these services entirely.

Early pilot programs in Yunnan and Guangxi provinces have shown promising results, with the device successfully diagnosing rare genetic conditions that might otherwise go undetected. Healthcare workers report that the device has already identified several cases of treatable genetic disorders.

"This technology could save lives in communities where genetic counseling and testing simply aren't available," says Dr. Wang Jiankang, BGI's Chief Medical Officer.`
    }
  ],
  bottomLine: "BGI's portable sequencer represents a major step toward democratizing genetic testing. By making sophisticated genomic analysis accessible in rural areas, the device could help address health disparities and enable earlier intervention for genetic diseases. The success of this initiative could serve as a model for improving healthcare access in developing regions worldwide."
}
},
{
id: 7,
title: "CATL Unveils Revolutionary Battery Health Monitoring System",
summary: "CATL's new AI-powered system can predict battery failure 6 months in advance, potentially revolutionizing EV maintenance and safety.",
category: "EVs",
source: "Bloomberg",
author: "Jennifer Zhang",
publishedAt: "2025-09-06T10:15:00Z",
votes: 234,
comments: 37,
views: "5.3k",
readTime: "3 min read",
image: "https://images.unsplash.com/photo-1558618666-fcd25c85cd64?w=400&h=250&fit=crop",
tags: ["CATL", "Battery Technology", "Predictive Maintenance", "EVs"],
originalUrl: "https://bloomberg.com/catl-battery-monitoring",
keyPoints: [
  "CATL's AI system can predict battery failure 6 months in advance",
  "Technology could revolutionize EV maintenance and improve safety"
],
fullContent: {
  keyTakeaways: [
    "CATL's AI system predicts battery failure up to 6 months in advance",
    "Technology monitors 50+ battery parameters in real-time",
    "Predictive maintenance could reduce EV maintenance costs by 30%",
    "System integration planned for major EV manufacturers in 2025"
  ],
  sections: [
    {
      heading: "Predictive Intelligence",
      content: `CATL, the world's largest battery manufacturer, has developed an AI-powered battery health monitoring system that can predict potential failures months before they occur. The system, called CellSense AI, continuously monitors battery performance and uses machine learning to identify early warning signs of degradation.

The technology addresses one of the biggest concerns about electric vehicles: unexpected battery failure. By providing advance warning, the system allows for preventive maintenance and could significantly improve EV reliability and safety.`
    },
    {
      heading: "How It Works",
      content: `CellSense AI monitors more than 50 different battery parameters:

**Thermal Patterns**: Detecting unusual heat generation that could indicate cell damage.
**Voltage Irregularities**: Identifying cells that aren't charging or discharging properly.
**Chemical Signatures**: Monitoring electrolyte composition for signs of degradation.
**Mechanical Stress**: Detecting physical changes that could lead to failure.

The AI model was trained on data from over 1 million battery packs, enabling it to recognize subtle patterns that human technicians might miss.`
    },
    {
      heading: "Industry Impact",
      content: `The predictive maintenance capability could transform the EV industry in several ways:

**Reduced Warranty Costs**: Manufacturers can address issues before expensive failures occur.
**Improved Safety**: Early warning prevents potentially dangerous battery incidents.
**Better Resale Value**: Detailed battery health data increases consumer confidence in used EVs.

Major automakers including Tesla, BMW, and Ford have expressed interest in integrating the technology into their vehicles. CATL plans to make the system standard in all new battery packs by 2026.`
    }
  ],
  bottomLine: "CATL's predictive battery monitoring represents a major advance in EV technology reliability. By shifting from reactive to predictive maintenance, the technology could address one of consumers' biggest concerns about electric vehicles. If widely adopted, this could accelerate EV adoption by making electric vehicles more reliable and cost-effective than traditional cars."
}
},
{
id: 8,
title: "Mindray's AI Ultrasound Achieves 95% Diagnostic Accuracy",
summary: "Chinese medical device giant Mindray's AI-enhanced ultrasound system outperforms human radiologists in detecting early-stage tumors.",
category: "MedTech",
source: "The Lancet Digital Health",
author: "Dr. Li Xin",
publishedAt: "2025-09-06T09:45:00Z",
votes: 167,
comments: 24,
views: "2.5k",
readTime: "5 min read",
image: "https://images.unsplash.com/photo-1559757175-0eb30cd8c063?w=400&h=250&fit=crop",
tags: ["Mindray", "Medical AI", "Ultrasound", "Diagnostics"],
originalUrl: "https://thelancet.com/mindray-ai-ultrasound",
keyPoints: [
  "Mindray's AI ultrasound system achieves 95% diagnostic accuracy",
  "Technology outperforms human radiologists in early tumor detection"
],
fullContent: {
  keyTakeaways: [
    "Mindray's AI-enhanced ultrasound achieves 95% accuracy in tumor detection",
    "System outperforms experienced radiologists in identifying early-stage cancers",
    "AI reduces diagnostic time from 30 minutes to 5 minutes per scan",
    "Technology approved for clinical use across China's healthcare system"
  ],
  sections: [
    {
      heading: "AI-Powered Diagnosis",
      content: `Mindray, China's largest medical device manufacturer, has achieved a breakthrough in medical imaging with an AI-enhanced ultrasound system that demonstrates 95% accuracy in detecting tumors. The system, called ResolutionAI, uses deep learning algorithms trained on over 500,000 ultrasound images.

In clinical trials involving 10,000 patients across 50 hospitals, the AI system consistently outperformed human radiologists in identifying early-stage tumors, particularly in breast, liver, and thyroid cancers where early detection is crucial for treatment success.`
    },
    {
      heading: "Technical Capabilities",
      content: `ResolutionAI incorporates several advanced features:

**Real-Time Analysis**: AI processes images as they're captured, providing instant feedback.
**Pattern Recognition**: Deep learning identifies subtle patterns invisible to human observers.
**Risk Stratification**: System categorizes findings by urgency and likelihood of malignancy.
**Automated Reporting**: Generates detailed diagnostic reports with confidence scores.

The system is particularly effective at detecting tumors smaller than 1cm, which are often missed in manual screenings but critical for early intervention.`
    },
    {
      heading: "Clinical Impact",
      content: `The implications for healthcare delivery are significant:

**Improved Access**: AI assistance allows less experienced technicians to perform high-quality diagnostics.
**Faster Diagnosis**: Reduced scan time means more patients can be screened daily.
**Cost Reduction**: Fewer missed diagnoses reduce the need for expensive follow-up procedures.

Dr. Zhang Mei, lead researcher on the clinical trial, notes: "This technology could be transformative for rural hospitals that lack specialized radiologists. The AI essentially puts expert-level diagnosis in every ultrasound machine."

China's National Health Commission has approved the system for widespread clinical use, with deployment planned across 1,000 hospitals by the end of 2025.`
    }
  ],
  bottomLine: "Mindray's AI ultrasound breakthrough demonstrates how artificial intelligence can enhance medical diagnosis beyond human capabilities. While questions remain about AI reliability and physician training, the technology's proven accuracy in clinical trials suggests it could significantly improve cancer detection rates, particularly in underserved areas with limited specialist access."
}
}
]

export default mockArticles